The Asia Pacific continuous glucose monitoring devices market size was estimated at USD 2.68 billion in 2025 and is predicted to reach around USD 12.34 billion by 2035, expanding at a CAGR of 16.50%from 2026 to 2035. The market is mainly fueled by the rise in diabetes cases, an older population, and the growing preference for advanced, real-time, and minimally invasive or non-invasive glucose management options.

Asia Pacific Continuous Glucose Monitoring Devices Market Statical Scope

The market is essential due to its large and quickly increasing diabetic population. Factors like rising obesity, an aging population, and a move towards advanced, technology-driven, and non-invasive diabetes management are driving this market. It plays a key role in enhancing patient care and lowering high treatment costs through effective real-time data monitoring.

The market is concentrating on creating more precise sensors and affordable devices to tackle high-cost challenges and boost accessibility. Rapid growth is expected in this market as these devices become vital for diabetes management and improving life quality in developing APAC countries.

Asia Pacific Continuous Glucose Monitoring Devices Market, By Product, 2025 (%)

• Sensors - The sensors segment plays a vital role in the market. These sensor are essential for real-time monitoring and are frequently replaced, which drives long-term market growth and adoption. They are the key component of continuous glucose monitoring devices, holding a 55% market share and providing real-time glucose measurements for diabetes patients.
• Device/Readers - The Device/Readers segment is important in the market as it serves as the main user interface for viewing real-time glucose data, essential for managing diabetes in a region with a rapidly increasing patient population. These devices read glucose levels from sensors and hold a 30% market share, making them vital for displaying glucose data and integrating with monitoring systems.

Asia Pacific Continuous Glucose Monitoring Devices Market, By Connectivity, 2025 (%)

• Bluetooth - The Bluetooth segment is significant in the market because it allows for smooth, real-time wireless transmission of glucose data to smartphones and digital health platforms. This is the most commonly used connectivity technology in continuous glucose monitoring devices, dominating with a 50% market share, facilitating seamless communication between devices and smartphones.

Asia Pacific Continuous Glucose Monitoring Devices Market, By Indication, 2025 (%)

• Type 1 Diabetes - The Type 1 Diabetes segment is essential in the market, driven by the rapidly increasing incidence rates, the urgent need for real-time tracking to avoid hypoglycemia, and the adoption of advanced insulin delivery systems. This chronic condition, where the pancreas produces little or no insulin, holds a 40% market share, with glucose monitoring devices being crucial for maintaining blood sugar control in these patients.
• Type 2 Diabetes - The Type 2 diabetes segment plays a vital role in the Market as it includes the largest and fastest-growing patient group. This growth is driven by factors like aging populations, obesity, and urbanization in various countries. Type 2 diabetes condition either resists insulin or fails to produce enough of it, making up 60% of the market share. As more individuals are diagnosed with Type 2 diabetes, the need for continuous glucose monitoring increases.

Asia Pacific Continuous Glucose Monitoring Devices Market, By Distribution Channel, 2025 (%)

• Pharmacies - The pharmacies segment is essential in the market because it serves as the main distribution channel, offering accessibility, convenience, and product advice. Traditional retail outlets selling glucose monitoring devices account for 35% of the market share, contributing to overall sales.

Competitive Landscape

The Continuous Glucose Monitoring (CGM) market in the Asia Pacific is very concentrated, with major companies like Abbott Laboratories, Dexcom, Inc., Medtronic plc, Senseonics Holdings, Inc., and Ascensia Diabetes Care leading the way. Abbott Laboratories is a key player in this area, recognized for its FreeStyle Libre systems that provide easy flash glucose monitoring without the need for fingersticks. Dexcom, Inc. is known for its Dexcom G6 and G7 CGM systems, which emphasize real-time continuous monitoring with high precision. The market is growing quickly, with China anticipated to see the fastest growth due to the rising demand for digital health solutions in managing diabetes. Companies are focusing heavily on launching new products, forming partnerships, and engaging in mergers and acquisitions to strengthen their presence in digital health and improve connectivity.

Recent Developments in the Asia Pacific Continuous Glucose Monitoring Devices Market

• In April 2026, Injewelme, a startup located in Singapore focused on creating contactless health monitoring technology, successfully secured $1.2 million in a funding round spearheaded by Temasek Trust's investment initiative, Catalytic Capital for Climate and Health. Injewelme plans to utilize this new capital to advance its contactless health monitoring technology by expanding its testing capabilities to include additional parameters, such as blood glucose levels, stress index, fatigue assessment, and hydration monitoring.

Segments Covered in the Report

By Product

• Sensors
• Device/Readers
• Applicators
• Transmitters

By Connectivity

• Bluetooth
• 4G/Cellular
• Near Field Communication (NFC)

By Indication

• Type 1 Diabetes
• Type 2 Diabetes

By Distribution Channel

• Pharmacies
• E-commerce
• Other